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I ndividuals with Lynch syndrome have a 20%-70% risk of developing colorectal cancer before the age of 70 years, [1] [2] [3] [4] have a higher risk for developing colorectal adenomas at a younger age, 5 and manifest rapid progression from colorectal adenoma to carcinoma. 6 It is estimated that 1%-3% of all colorectal cancer is caused by Lynch syndrome. 7 The increased risk of colorectal cancer in those with Lynch syndrome is caused by pathogenic germline mutations in genes involved in DNA mismatch repair, ie, MLH1, MSH2, MSH6, PMS2, or EPCAM. [7] [8] [9] [10] Considering the high lifetime risk of developing colorectal cancer in individuals with Lynch syndrome, it is very relevant to study whether modifiable lifestyle factors can affect the risk for developing this hereditary cancer. Several modifiable lifestyle factors affect the risk of sporadic colorectal cancer, among them are smoking 11 and alcohol consumption. 12 However, this association has been studied only sparsely in Lynch syndrome. [13] [14] [15] So far, only retrospective studies on smoking and colorectal cancer risk in individuals with Lynch syndrome were performed, [13] [14] [15] these cohort 14, 15 and case-control studies 13 showed that smoking was associated with an increased risk of colorectal cancer. Due to the retrospective nature, the information on smoking history was limited in one of these studies, 15 as it had to be obtained partly from medical records or family reports. Moreover, the case-control study 13 included persons who were not all confirmed carriers of a mismatch repair gene mutation. Likewise for alcohol intake, the association with colorectal cancer in Lynch syndrome has only been studied retrospectively in these studies. 13, 15 Neither study detected a significant association between alcohol intake and colorectal cancer risk.
The aim of this study was to prospectively assess the association between smoking and/or alcohol intake and colorectal adenoma development in a cohort study of persons with Lynch syndrome. To our best knowledge, the association with colorectal adenomas has not been studied before, as previous studies on Lynch syndrome focused on colorectal carcinoma risk. [13] [14] [15] In the general population, smoking shows a stronger association with development of colorectal adenomas than with carcinoma. 11, 16 For individuals with Lynch syndrome who undergo regular surveillance colonoscopies, colorectal adenomas are removed, which lowers their risks for colorectal carcinoma. 17, 18 Therefore, it is very relevant to study whether the risk of developing colorectal adenomas is modifiable.
Methods Population
Details of the prospective cohort of individuals with Lynch syndrome (the GeoLynch study) were described earlier. 19 In short, we identified subjects known to have a pathogenic mutation in one of the mismatch repair genes-as confirmed by a clinical genetics center-through the Netherlands Foundation for the Detection of Hereditary Tumors in Leiden, the Radboud University Nijmegen Medical Centre, and the University Medical Centre in Groningen, The Netherlands. Participants had to be Dutch-speaking, white, mentally competent to participate in the study, and between 18 and 80 years of age to be eligible for our study. Additionally, subjects with familial adenomatous polyposis, inflammatory bowel disease, a personal history of a complete proctocolectomy or colostomy, and those who were terminally ill were excluded.
A total of 713 eligible mutation carriers were invited to participate between July 2006 and July 2008, with the approval of their medical specialist. Of these, 73% (499 of 713) agreed to participate. Retrieval of medical and personal information was complete for 486 of 499 persons. One hundred of these 486 individuals were excluded from our analysis, as they did not have a colonoscopy during the follow-up of this study. These 100 individuals could not have been diagnosed with colorectal adenoma (the primary outcome of this study), as diagnosis requires completion of a colonoscopy. Smoking behavior and alcohol intake of these 100 individuals was comparable with the total cohort: there were 18 smokers, 38 former smokers, and 43 never smokers, and the median alcohol intake was 6 g/day (1-13 g/day). The total cohort for this study consisted of 386 subjects, who came from at least 161 families.
Approval for this study was obtained from the Medical Ethical Committee of the Radboud University Nijmegen Medical Centre. All participants provided written informed consent.
Exposure Assessment
Using structured questionnaires, we collected detailed selfreported information on smoking and possible confounding factors, eg, physical activity level, height, and weight. Smoking information included smoking status at recruitment (current, former, ever), duration of smoking, type of tobacco product (cigarettes, pipe, cigar), and number of cigarettes smoked per day. Because 224 of the 245 ever smokers in the cohort smoked cigarettes, we did not distinguish between type of tobacco in our analyses.
Information on alcohol intake was extracted from a selfadministered, validated food frequency questionnaire. 20, 21 In this questionnaire, subjects reported type and frequency of intake of alcoholic drinks during the past month. From this information, in combination with data from the Dutch food composition table, 22 we calculated intake of alcohol in grams per day. We used the data of all persons in the cohort to create tertiles of alcohol intake. Moreover, we evaluated whether the alcohol intake was below the recommendations set by the World Cancer Research Fund 12 of Յ1 glass per day for women (Յ10 g alcohol) and of Յ2 glasses per day for men (Յ20 g alcohol).
Outcome Data
Medical information was gathered via the participating centers. From the medical records, we extracted information on date and number of colonoscopies, colon operations, and incidence of cancer and adenomatous polyps before recruitment and during follow-up until July 2009. We ascertained detailed information about location, size, and histology for all documented polyps that occurred during follow-up from pathology records.
Data Analysis
The outcome of our analysis was the time to diagnosis of the first pathology-confirmed colorectal adenomatous polyp. Person-time started at the date participants had completed the questionnaires. For the subjects without an adenoma diagnosis, we censored the person-time at the date of diagnosis of colorectal or extracolonic cancer, metastasis or death, the date of the last colonoscopy during follow-up, whichever came first.
We used Cox proportional hazard regression to assess hazard ratios (HR) for the association between smoking and/or alcohol intake and development of colorectal adenomas. We used robust estimates of variance in the calculation of the 95% confidence interval (CI) to account for dependency of observations within families. The proportional hazard assumption was not violated, as evaluated by the goodness-of-fit test using Schoenfeld residuals (P Ͼ .05).
In additional analyses on number of cigarettes smoked per day, number of years smoked, and pack-years of smoking, we combined current and former smokers and excluded the never smokers. In test for trend analyses on those smoking variables, we assigned the median score for each tertile of the different smoking variables to each individual in this tertile. This new variable was included in the Cox model as a continuous variable.
To assess whether associations differed for prevalent vs incident colorectal adenoma cases, we stratified our analysis for history of colorectal adenomas or carcinomas. To assess multiplicative interaction between smoking and alcohol intake, we created categories based on both smoking (never, current, former smokers) and alcohol intake (low vs high intake, based on median split). We assessed the HR for development of colorectal adenomas within each category vs "never smokers and low alcohol intake" as reference category. To test for multiplicative interaction, we used a log likelihood ratio test that compared a model with interaction terms of alcohol ϫ smoking to a model without these interaction terms.
We assessed whether the following variables affected the associations between smoking, alcohol, and colorectal adenomas: age (continuous), sex, history of colorectal adenomas or carcinomas (yes/no), number of colonoscopies during follow-up (continuous), colonic resection (yes/no), body mass index (continuous), nonsteroidal anti-inflammatory drug use (more or less than 1 time/week), education (categorical: high vs lower educated), type of gene mutation, physical activity level (categorical: high vs lower physically active), energy intake (continuous), red and processed meat intake (continuous), smoking (categorical: never/former/current, in the analyses of alcohol), alcohol (continuous, in the analyses of smoking). Covariates were included in multivariate models if correlated with the exposure (smoking or alcohol) and the outcome (colorectal adenomas) in univariate analyses; using backward elimination, covariates remained in the final models if they produced changes in the HR of Ն10%, while age, sex and number of colonoscopies were always included in the models. To test baseline differences between individuals with and without colorectal adenomas, we used 2 or Fisher's test for categorical variables and Wilcoxon's rank sum test for continuous variables.
All analyses were performed using Stata software (Stata/SE 11.0 for Windows, StataCorp LC, College Station, TX).
Results
During a median follow-up of 10 months, 58 of 386 subjects in our cohort developed a histologically confirmed colorectal adenoma. Table 1 shows that these subjects were slightly older, slightly less educated, and more often men compared to the total cohort. In addition, these subjects were more likely to have had colorectal adenomas in the past and to have had at least one colonoscopy during follow-up compared with the total cohort. There were more smokers and former smokers, and alcohol intake appeared to be slightly higher among cases than among the total cohort (Table 1 ).
Former and current smokers more often had a history of colorectal adenomas, were slightly less educated, and had slightly higher alcohol intake than never smokers. In addition, former and current smokers were more likely to have had at least one colonoscopy during follow-up and to have had a partial or subtotal colonic resection. Subjects with a higher intake of alcohol were more often male, more often had a history of colorectal adenomas, were slightly higher educated, were more often current or former smoker, and more often had a colonoscopy during follow-up (data not shown).
Current and former smoking was associated with an increased risk of colorectal adenoma development during follow-up. The adjusted HR for current smokers was 6.13 (95% CI, 2.84 -13.22) and for former smokers 3.03 (95% CI, 1.49 -6.16) compared with never smokers (Table 2) . Among current and former smokers, a higher number of pack-years was associated with an increased risk of colorectal adenomas: P for trend was .03. A higher number of cigarettes smoked per day and a longer duration of smoking were also associated with an increased risk of colorectal adenomas compared to a low number of cigarettes or a shorter duration, although not statistically significant (Table 2) .
There was a trend of alcohol intake increasing the risk of colorectal adenomas; however, this was not statistically significant after adjustment for smoking status and other confounding factors; adjusted HR for the highest tertile of alcohol intake (median, 22 g/day) vs the lowest tertile of alcohol intake (0.4 g/day) was 1.56 (95% CI, 0.71-3.43) ( Table 3) . Similarly, in the continuous model, the association of alcohol intake and risk of colorectal adenomas was not statistically significant after adjustment for smoking status and other factors. Alcohol intake was also evaluated according to the recommendations of the World Cancer Research Fund (no more than 1 glass/day for women, 2 glasses/day for men). There was again a trend of alcohol intake above the recommendation increasing the risk of colorectal adenomas, but this was not statistically significant: adjusted HR for persons who had an intake above the recommendations vs persons who met the recommendation was 1.56 (95% CI, 0.71-3.43).
There was no interaction between alcohol intake (low or high, based on a median split) and smoking status (never, former, current smokers): P ϭ .70 (Table 4) .
Stratified analyses showed that associations for alcohol intake or smoking did not substantially differ among individuals with or without a history of colorectal adenomas or carcinomas (data not shown).
Discussion
In people with Lynch syndrome, current smoking was associated with a more than 6-fold increased risk, whereas former smoking was associated with a 2-fold increased risk compared with never smoking. Although there was a trend for alcohol increasing the risk of colorectal adenomas in our cohort of persons with Lynch syndrome, this was not statistically significant after adjusting for smoking. Two retrospective cohort studies found that smoking was associated with increased risk of colorectal carcinomas in Lynch syndrome, 14, 15 although their risk estimates for colorectal carcinomas are lower than the estimates for adenomas in this study. Similarly, in studies in the general population, smoking appears to be more strongly associated with sporadic colorectal adenoma than with sporadic colorectal carcinoma occurrence. 11, 16 This difference in strength of the association may be partly related to the fact that in colorectal carcinoma studies, reference group participants usually did not undergo a colonoscopy, 11 while in many adenoma studies, reference groups were adenoma-free as ascertained by colonoscopy. 16 Undiagnosed adenoma or (early stage) carcinoma cases in reference groups may attenuate any association between smoking and colorectal carcinomas. This attenuation may also appear in studies on Lynch syndrome, 14, 15 as not all the individuals without colorectal cancer in those studies had undergone colonoscopies to confirm that they were really tumor-free.
The strength of the association between smoking and colorectal adenoma development appears to be stronger in subjects with Lynch syndrome than in sporadic adenoma cases. The underlying explanation for this is unknown, but may be that smoking is involved in epigenetic modification of mismatch repair genes. 23 Smoking has been found to be associated with an increased risk of sporadic colorectal carcinomas that show hypermethylation in the promoter region of MLH1 23 and with an increased risk of carcinomas that show microsatellite instability. 23, 24 Microsatellite instability is one of the features of colorectal adenomas and carcinomas in Lynch syndrome. 5, 25, 26 As persons with Lynch syndrome have a germline mutation in one allele of a mismatch repair gene, disruption of the unaffected copy can result in microsatellite instability and ultimately into colorectal carcinoma. 27 It has been suggested that hypermethylation of the promoter of the MLH1 28 and MSH2 29 genes can serve as a second hit in Lynch syndrome.
Our findings suggest that smoking cessation may be beneficial for persons with Lynch syndrome who smoke, as it will lower their risk of colorectal adenomas compared with persons who continue to smoke. Our findings contrast with the findings from an earlier study on colorectal carcinomas in persons with Lynch syndrome from the Colon Cancer Family registry and the Texas MD Anderson Cancer Center, 14 which found a decreased risk for former smokers compared with never smokers. The authors of that article acknowledged that their findings could be a result of bias, as a large body of evidence for several types of cancer shows that although smoking cessation decreases the risk of cancer, the risk usually remains elevated, compared with persons who have never smoked. 30, 31 In our own cohort, due to a lack of power, it was not possible to further study the association of smoking history in former smokers, eg, by stratifying for the numbers of years since quitting.
Alcohol intake was not statistically significantly associated with increased risk of colorectal adenoma occurrence in Lynch syndrome after adjustment for smoking. In the general population, alcohol intake is associated with a modest increased risk of colorectal adenomas. For instance, in the EPIC-Heidelberg cohort, 32 alcohol intake between 15 and 30 g/day was associated with increased risk for colorectal adenomas (odds ratio ϭ 1.55; 95% CI, 1.19 -2.02) compared with the lowest intake group (Ͻ5 g/day). Although our findings are in agreement with earlier findings in persons with Lynch syndrome, 13,15 the absence of a statistically significant association may merely be a result of the limited size of our cohort. Although this is one of the largest prospective cohorts of confirmed cases of Lynch syndrome, its size narrows the extent to which we can observe associations. The power to observe associations with alcohol intake could be further diminished by the fact that alcohol intake usually varies extensively within-persons, particularly when alcohol intake is high. 33 Moreover, although self-reported frequency questionnaires are considered to give valid and reliable estimations of alcohol intake over short reference periods, 34 this short period may not be representative of long-term intake of alcohol. a Subjects were classified as low or high alcohol consumers based on the median of the total population. The median intake of alcohol in the low alcohol group was 2 g/day (range, 0 -7 g) and in the high alcohol group 18 g/day (range, 7-94 g). b Adjusted for age, sex, number of colonoscopies (continuous), colonic resection (yes/no), and body mass index (continuous).
An important strength of our study in comparison to other studies is the prospective design, which has the advantage that information on smoking and alcohol was collected before the events of interest. The extensive baseline questionnaires allowed us to explore confounding of our results by several demographic, clinical, and lifestyle factors and to perform multivariate adjusted analyses. Nevertheless, residual confounding by other lifestyle factors might still partly explain our findings. Other strengths are the high participation rate in our cohort and the inclusion of only confirmed mismatch repair-gene mutation carriers. These factors make our findings generalizable to regularly screened persons with Lynch syndrome in other clinical series.
Our findings can help to formulate recommendations on smoking and alcohol intake to lower the risk of colorectal carcinomas for Lynch syndrome-affected persons. However, such recommendations are only valid if modification of colorectal adenoma risk translates into a change of colorectal carcinoma risk and thus only when colorectal carcinomas develop through the adenoma-carcinoma pathway. That this pathway is indeed important, is supported by the fact that previous surveillance studies showed that through polypectomy, the incidence of colorectal carcinomas was lowered in persons with Lynch syndrome. 17, 18 In conclusion, our results suggest that modifiable lifestyle factors clearly affect colorectal adenoma risk in individuals with Lynch syndrome. As these persons have a high risk of developing colorectal cancer, any lifestyle modification that could help to lower this risk is vital. Lifestyle advice on smoking cessation should become standard care during the clinical screening of these individuals.
